MedPath

Tazret

Brand Name: Tazret

Generic Name: Tazarotene

Active
Registration Number

DRP-8173

Dosage Form

Topical Gel

Issuance Date

March 31, 2022

Expiry Date

May 10, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500mcg/g (0.05%w/w)
PackagingAluminum Tube x 15g (Box of 1's) Physician's sample: Aluminum Tube x 3g (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antipsoriatic for topical use
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

TazaroteneActive
Monograph: Tazarotene

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform